Trial watch: Immune checkpoint blockers for cancer therapy
Sign Up to like & getrecommendations! Published in 2017 at "OncoImmunology"
DOI: 10.1080/2162402x.2017.1373237
Abstract: ABSTRACT Immune checkpoint blockers (ICBs) are literally revolutionizing the clinical management of an ever more diversified panel of oncological indications. Although considerable attention persists around the inhibition of cytotoxic T lymphocyte-associated protein 4 (CTLA4) and… read more here.
Keywords: immune checkpoint; checkpoint blockers; watch immune; trial watch ... See more keywords